Statement: no cardiac or bowel-related adverse events were recorded in the primary trial. ovarian adenomatoid tumor is a rare benign mesothelial tumor that arises from the ovary. it is characterized by the presence of gland-like structures.
Primary_evidence: Adverse Events 1:   Total: 2/30 (6.67%)   Dry Eyes  [1]1/30 (3.33%)   Diarrhea  [2]1/30 (3.33%)